Short-term intravenous milrinone for severe congestive heart failure: The good, bad, and not so good

Pharmacotherapy

Volumn 17, Issue 2, 1997, Pages 371-374

  Varriale, Philip ^a   Ramaprasad, Sunil ^a  

^a CABRINI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; MILRINONE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; DOSE TIME EFFECT RELATION; FEMALE; HEART EJECTION FRACTION; HEART HEMODYNAMICS; HEART INDEX; HEART VENTRICLE TACHYCARDIA; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; LUNG CAPILLARY PRESSURE; MALE; VASODILATATION;

AGED; CARDIOTONIC AGENTS; FEMALE; HEART FAILURE, CONGESTIVE; HEMODYNAMIC PROCESSES; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; MILRINONE; PYRIDONES; VASODILATOR AGENTS;

EID: 0030971416     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Sanders MR, Kostis JB, Frishman WH. The use of inotropic agents in acute and chronic congestive heart failure. Med Clin North Am 1989;73:283-314.
2. Francis GS, Archer SL. Diagnosis and management of acute congestive heart failure in the intensive care unit. J Intensive Care Med 1989;4:84-92.
3. Unverferth DV, Magorien RD, Altschuld R, Kolibash AJ, Lewis PP, Leier CV. The hemodynamic and metabolic advantages gained by a three-day infusion of dobutamine in patients with congestive cardiomyopathy. Am Heart J 1983;106:29-34.
4. Jaski BE, Fifer MA, Wright RF, Braunwald E, Colucci WS. Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure. J Clin Invest 1985;75:643.
5. Benotti JR, Lesko LJ, McCue JE. Pharmacokinetics and pharmacodynamics of milrinone in chronic congestive heart failure. Am J Cardiol 1985;56:685-9.
6. Konstam MA, Cody RJ. Short-term use of intravenous milrinone for heart failure. Am J Cardiol 1995;75:822.
7. Anderson JL, Baim DS, Fein SA, Goldstein RA, LeJemtel TH, Likoff MJ. Efficacy and safety of sustained (48 hour) intravenous infusions of milrinone in patients with severe congestive heart failure: a multicenter study. J Am Coll Cardiol 1987;9:711-22.
8. Monrad ES, McKay RG, Baim DS, et al. Improvement in indexes of diastolic performance in patients with congestive heart failure treated with milrinone. Circulation 1984;70: 1030-7.
9. Colucci WS, Wright RF, Jaski BE, Fifer MA, Braunwald E. Milrinone and dobutamine in severe heart failure: differing hemodynamic effects and individual patient responsiveness. Circulation 1986;73(suppl III):III. 175-83.
10. Sanofi Winthrop Pharmaceuticals. Primacor (milrinone lactate) prescribing information. New York, NY; 1995.
11. Grose R, Strain J, Greenberg M, Lejemtel TH. Systemic and coronary effects of intravenous milrinone and dobutamine in congestive heart failure. J Am Coll Cardiol 1986;7:1107-13.
12. Biddle TL, Benotti JR, Creager MA, et al. Comparison of intravenous milrinone and dobutamine for congestive heart failure secondary to either ischemic or dilated cardiomyopathy. Am J Cardiol 1987;59:1345-50.
13. Monrad ES, Baim DS, Smith HS, Lanoue AS. Milrinone, dobutamine, and nitroprusside: comparative effects on hemodynamics and myocardial energetics in patients with severe congestive heart failure. Circulation 1986;73(suppl III):III.168-74.
14. Prielipp R, MacGregor DA, Butterworth JF, et al. Pharmacodynamics and pharmacokinetics of milrinone administration to increase oxygen delivery in critically ill patients. Chest 1996;109:1291-1301.
15. Bristow MR, Ginsburg R, Minobe W. Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. N Engl J Med 1982;307:205-11.
16. Scalea TM, Donovan R. Amrinone as an inotrope in managing hypermetabolic surgical stress. J Trauma 1992;32:372-9.
17. Jones JI, Gengo PJ, Dodam JR. Amrinone combined with dobutamine improves hemodynamic and oxygen delivery without down-regulation of cardiac β-adrenergic receptor density in porcine endotoxemia. Shock 1995;3:224-34.
18. Barton P, Garcia J, Kouatli A, et al. Hemodynamic effects of intravenous milrinone lactate in pediatric patients with septic shock. Chest 1996;109:1302-12.
19. Unverferth DV, Blanford M, Kates RE, Leier CV. Tolerance to dobutamine after a 72 hour continuous infusion. Am J Med 1980;69:262-6.
20. Anderson JL, Askins JC, Gilbert EM, Menlove RL, Lutz JR. Occurrence of ventricular arrhythmias in patients receiving acute and chronic infusions of milrinone. Am Heart J 1986;111:466-74.